Drug details

Neuraceq (florbetaben f 18 injection)

type of Diagnostic Imaging Agents

Neuraceq (florbetaben F 18) Injection is a molecular imaging agent used for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• severe dizziness
• swelling of your face, lips, tongue, or throat, and

The following drugs are related to Neuraceq, either as a replacement or used together:

• Ionetix (ammonia n 13)
• Aricept (donepezil)
• Exelon (rivastigmine tartrate)
• Exelon Patch (rivastigmine transdermal system)
• Vizamyl (flutemetamol f 18 injection)
• Octreoscan (indium in -111 pentetreotide kit for intravenous use)
• Jeanatope 1-125 (iodinated 1-125 albumin injection)
• Namenda (memantine hcl)
• Namenda XR (memantine hydrochloride extended release capsules)
• Narcan (naloxone hydrochloride injection)
• Xenoview (xenon xe 129 gas blend)